SPTX Financials

Income Statement
MetricQ2 2026
Revenue
0
Cost of Revenue
0
Gross Profit
0
Operating Expenses
65.8M
R&D
24.6M
SG&A
41.2M
Operating Income
-65808000
EBITDA
-65782000
Net Income
-62600000
EPS (Basic)
$-1.78
EPS (Diluted)
$-1.78
Shares (Diluted)
35.2M
MarketsMoversWatchlist
Seaport Therapeutics (SPTX) — Financials